PAPER Wang H, Ma J, Tan Y, Wang Z, Sheng C, Chen S, Ding J
SEARCH RESULTS
331008 RESULTS
PAPER Yang H, Zhuo JM, Chu J, Chinnici C, Praticò D
Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
Biol Psychiatry. 2010 Nov 15;68(10):922-9. PubMed: 20570249PAPER Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, Bleckmann D, Betschart C, Hoyer D, Frentzel S, Difiglia M, Paganetti P, Hersch SM
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.
Mol Neurodegener. 2010;5:26. PubMed: 20569486PAPER Uro-Coste E, Russano de Paiva G, Guilbeau-Frugier C, Sastre N, Ousset PJ, da Silva NA, Lavialle-Guillotreau V, Vellas B, Delisle MB
Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review.
Clin Neuropathol. 2010 Jul-Aug;29(4):209-16. PubMed: 20569670PAPER Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, Bolzoni E, Galbiati M, Fontana E, Marino M, Carra S, Bendotti C, De Biasi S, Poletti A
The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
Hum Mol Genet. 2010 Sep 1;19(17):3440-56. PubMed: 20570967PAPER Wagner D, Pargas C, Donnenfeld AE
Moderately increased risks of Down's syndrome (1/51-1/270) identified on first trimester sequential screening: what do patients do with this information?
J Med Screen. 2010;17(1):4-7. PubMed: 20356938PAPER Mollenhauer B, Schlossmacher MG
CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies.
J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):590-1. PubMed: 20522867PAPER Bousquet M, Gibrat C, Ouellet M, Rouillard C, Calon F, Cicchetti F
Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases.
J Neurochem. 2010 Sep;114(6):1651-8. PubMed: 20569301PAPER Antonini A, Bondiolotti G, Natuzzi F, Bareggi SR
Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa.
Eur Neuropsychopharmacol. 2010 Oct;20(10):683-7. PubMed: 20570113PAPER Ducharme N, Banks WA, Morley JE, Robinson SM, Niehoff ML, Mattern C, Farr SA
Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration.
Eur J Pharmacol. 2010 Sep 1;641(2-3):128-34. PubMed: 20570588PAPER Meulenbroek O, Rijpkema M, Kessels RP, Rikkert MG, Fernández G
Autobiographical memory retrieval in patients with Alzheimer's disease.
Neuroimage. 2010 Oct 15;53(1):331-40. PubMed: 20570740PAPER Rodríguez-Rodríguez E, Vázquez-Higuera JL, Sánchez-Juan P, Mateo I, Pozueta A, Martínez-García A, Frank A, Valdivieso F, Berciano J, Bullido MJ, Combarros O
Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk.
J Alzheimers Dis. 2010;21(2):619-25. PubMed: 20571217PAPER Li RC, Guo SZ, Lee SK, Gozal D
Neuroglobin protects neurons against oxidative stress in global ischemia.
J Cereb Blood Flow Metab. 2010 Nov;30(11):1874-82. PubMed: 20571522PAPER Mielke MM, Lyketsos CG
Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?
Neuromolecular Med. 2010 Dec;12(4):331-40. PubMed: 20571935Benjamin Wolozin on Law and Disorder—APPswe Patent Suits Raise Ruckus Again
COMMENT The report by Esther Landhuis and Gabrielle Strobel reflects the inherent intellectual and financial turbulence that evolves when advancing technology interfaces with the patent system and commercial system. First, let’s examine the patent issues. It is c
Current Filters
No filters selected